Tri Locum Partners LP Quant / Systematic

Location: New York, NY

CIK: 0001826434 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value: $403M (100.0% shares, 0.0% debt)

Holdings (34)

WALGREENS BOOTS ALLIANCE INC 10.5%
Value $42.27M Shares 770,000 Est. Cost $39.88 Unrealized
WALGREENS BOOTS ALLIANCE INC 10.5%
Value $42.27M Shares 770,000 Est. Cost $39.88 Unrealized
REGN REGENERON PHARMACEUTICALS 7.6%
Value $30.61M Shares 64,705 Est. Cost $492.67 Unrealized -1.7%
MDT MEDTRONIC PLC 7.0%
Value $28.31M Shares 239,644 Est. Cost $96.06 Unrealized +5.9%
JNJ JOHNSON & JOHNSON 6.9%
Value $27.71M Shares 168,634 Est. Cost $128.00 Unrealized +10.0%
HORIZON THERAPEUTICS PUB L 6.7%
Value $27.01M Shares 293,426 Est. Cost $92.04 Unrealized
BAX BAXTER INTL INC 6.6%
Value $26.49M Shares 314,136 Est. Cost $71.05 Unrealized +0.6%
BMY BRISTOL-MYERS SQUIBB CO 6.1%
Value $24.68M Shares 390,992 Est. Cost $51.02 Unrealized +0.0%
WALGREENS BOOTS ALLIANCE INC 5.4%
Value $21.95M Shares 399,842 Est. Cost $39.88 Unrealized
JAZZ JAZZ PHARMACEUTICALS PLC 4.5%
Value $18.14M Shares 110,382 Est. Cost $164.55 Unrealized 0.0%
HUM HUMANA INC 3.7%
Value $14.96M Shares 35,693 Est. Cost $381.33 Unrealized 0.0%
NUANCE COMMUNICATIONS INC 3.6%
Value $14.55M Shares 333,482 Est. Cost $43.64 Unrealized
LLY LILLY ELI & CO 2.2%
Value $9.023M Shares 48,299 Est. Cost $141.36 Unrealized +31.6%
9 METERS BIOPHARMA INC 1.9%
Value $7.774M Shares 6,644,337 Est. Cost $1.10 Unrealized
TGTX TG THERAPEUTICS INC 1.8%
Value $7.163M Shares 148,620 Est. Cost $41.34 Unrealized +16.2%
PTGX PROTAGONIST THERAPEUTICS INC 1.7%
Value $6.659M Shares 257,086 Est. Cost $21.52 Unrealized +17.6%
MYOVANT SCIENCES LTD 1.6%
Value $6.608M Shares 321,101 Est. Cost $21.48 Unrealized
TRILLIUM THERAPEUTICS INC 1.5%
Value $6.218M Shares 578,930 Est. Cost $12.77 Unrealized
ACRS ACLARIS THERAPEUTICS INC 1.0%
Value $4.138M Shares 164,199 Est. Cost $19.56 Unrealized 0.0%
CLDX CELLDEX THERAPEUTICS INC NEW 1.0%
Value $4.051M Shares 196,672 Est. Cost $22.96 Unrealized 0.0%
SNDX SYNDAX PHARMACEUTICALS INC 1.0%
Value $4.031M Shares 180,261 Est. Cost $21.37 Unrealized +5.7%
INFIQ INFINITY PHARMACEUTICALS INC 1.0%
Value $3.911M Shares 1,210,863 Est. Cost $3.34 Unrealized 0.0%
CASI PHARMACEUTICALS INC 0.9%
Value $3.6M Shares 1,500,000 Est. Cost $2.40 Unrealized
BDTX BLACK DIAMOND THERAPEUTICS I 0.9%
Value $3.467M Shares 142,911 Est. Cost $27.39 Unrealized -1.5%
LIFESCI ACQUISITION II CORP 0.8%
Value $3.042M Shares 300,000 Est. Cost $10.67 Unrealized
AERIE PHARMACEUTICALS INC 0.6%
Value $2.502M Shares 140,000 Est. Cost $17.88 Unrealized
AERIE PHARMACEUTICALS INC 0.6%
Value $2.502M Shares 140,000 Est. Cost $17.88 Unrealized
CYCLACEL PHARMACEUTICALS INC 0.5%
Value $2.086M Shares 293,419 Est. Cost $7.11 Unrealized
BELLUS HEALTH INC NEW 0.4%
Value $1.46M Shares 380,237 Est. Cost $3.84 Unrealized
AVADEL PHARMACEUTICALS PLC 0.4%
Value $1.449M Shares 160,256 Est. Cost $9.04 Unrealized
IMTX IMMATICS N.V 0.3%
Value $1.365M Shares 121,743 Est. Cost $11.34 Unrealized 0.0%
AERIE PHARMACEUTICALS INC 0.3%
Value $1.224M Shares 68,472 Est. Cost $17.88 Unrealized
EOLS EVOLUS INC 0.3%
Value $1.053M Shares 81,025 Est. Cost $9.22 Unrealized 0.0%
AMRX AMNEAL PHARMACEUTICALS INC 0.2%
Value $939K Shares 139,470 Est. Cost $5.54 Unrealized 0.0%